Why apply as a participant?As a participant in a Clinical Trial you contribute to new knowledge, and help the Pharmaceutical Industry to bring new medical treatment to the market. Thanks to kindly and voluntary participation from thousands of people through the years, CCBR Clinical Research has succeeded to contribute to approval of new and more efficient treatments, for the benefit of present and future generations. Examples include the medication Prolia® developed to treat people with Osteoporosis, as well as Razilez®, which is developed to treat people with high cholesterol. Both medications are now improving the life quality of thousands of people all over the world.
A participant in a Clinical Trial will get a thorough medical examination by a doctor and will receive free of charge treatment with a new medication during the Clinical Trial. All participants are under continuous care of qualified specialist team (physicians and nurses) during the trial period.
Clinical Trials are conducted under the rules and guidance such as “Good Clinical Practice”, securing that the participants interests and safety is paramount and beyond the public and scientific interests of the trial. The State Medicines Control Agency issues the permission to conduct Clinical Trials after receiving the positive accepts by local Ethics Committees. These institutions protect the participants’ interests and monitor the process of Clinical Trials. This means, the participants well-being is of first priority. All participants have every right to leave a Clinical Trial at any time - without giving any reason.
Click here to read more about the frequently asked questions